» Articles » PMID: 17552023

Hepatitis C Virus Proteins

Overview
Specialty Gastroenterology
Date 2007 Jun 7
PMID 17552023
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatitis C virus (HCV) encodes a single polyprotein, which is processed by cellular and viral proteases to generate 10 polypeptides. The HCV genome also contains an overlapping +1 reading frame that may lead to the synthesis of an additional protein. Until recently, studies of HCV have been hampered by the lack of a productive cell culture system. Since the identification of HCV genome approximately 17 years ago, structural, biochemical and biological information on HCV proteins has mainly been obtained with proteins produced by heterologous expression systems. In addition, some functional studies have also been confirmed with replicon systems or with retroviral particles pseudotyped with HCV envelope glycoproteins. The data that have accumulated on HCV proteins begin to provide a framework for understanding the molecular mechanisms involved in the major steps of HCV life cycle. Moreover, the knowledge accumulated on HCV proteins is also leading to the development of antiviral drugs among which some are showing promising results in early-phase clinical trials. This review summarizes the current knowledge on the functions and biochemical features of HCV proteins.

Citing Articles

Contemporary Insights into Hepatitis C Virus: A Comprehensive Review.

Sallam M, Khalil R Microorganisms. 2024; 12(6).

PMID: 38930417 PMC: 11205832. DOI: 10.3390/microorganisms12061035.


Mechanisms and Clinical Significance of Pharmacokinetic Drug Interactions Mediated by FDA and EMA-approved Hepatitis C Direct-Acting Antiviral Agents.

Murray M Clin Pharmacokinet. 2023; 62(10):1365-1392.

PMID: 37731164 DOI: 10.1007/s40262-023-01302-x.


Hepatitis C Virus: Insights Into Its History, Treatment, Challenges, and Future Directions.

Bernal L, Soti V Cureus. 2023; 15(8):e43924.

PMID: 37614826 PMC: 10443603. DOI: 10.7759/cureus.43924.


An Update on the Metabolic Landscape of Oncogenic Viruses.

Gaballah A, Bartosch B Cancers (Basel). 2022; 14(23).

PMID: 36497226 PMC: 9738352. DOI: 10.3390/cancers14235742.


Hepatitis C Virus Infection and Intrinsic Disorder in the Signaling Pathways Induced by Toll-Like Receptors.

Redwan E, Aljadawi A, Uversky V Biology (Basel). 2022; 11(7).

PMID: 36101469 PMC: 9312352. DOI: 10.3390/biology11071091.


References
1.
Owsianka A, Tarr A, Juttla V, Lavillette D, Bartosch B, Cosset F . Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein. J Virol. 2005; 79(17):11095-104. PMC: 1193588. DOI: 10.1128/JVI.79.17.11095-11104.2005. View

2.
MacDonald A, Harris M . Hepatitis C virus NS5A: tales of a promiscuous protein. J Gen Virol. 2004; 85(Pt 9):2485-2502. DOI: 10.1099/vir.0.80204-0. View

3.
Drummer H, Maerz A, Poumbourios P . Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins. FEBS Lett. 2003; 546(2-3):385-90. DOI: 10.1016/s0014-5793(03)00635-5. View

4.
Yao N, Hesson T, Cable M, Hong Z, Kwong A, Le H . Structure of the hepatitis C virus RNA helicase domain. Nat Struct Biol. 1997; 4(6):463-7. DOI: 10.1038/nsb0697-463. View

5.
Shirota Y, Luo H, Qin W, Kaneko S, Yamashita T, Kobayashi K . Hepatitis C virus (HCV) NS5A binds RNA-dependent RNA polymerase (RdRP) NS5B and modulates RNA-dependent RNA polymerase activity. J Biol Chem. 2002; 277(13):11149-55. DOI: 10.1074/jbc.M111392200. View